Wockhardt Limited (WOCKPHARMA.BO)
INR 1264.45
(4.26%)
INR 1264.45
(4.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.24 Billion INR | -49.12% |
| 2022 | 15.35 Billion INR | -21.0% |
| 2021 | 19.43 Billion INR | 24.23% |
| 2020 | 15.64 Billion INR | -4.02% |
| 2019 | 16.29 Billion INR | -14.73% |
| 2018 | 19.11 Billion INR | -9.97% |
| 2017 | 21.22 Billion INR | -9.77% |
| 2016 | 23.52 Billion INR | -17.15% |
| 2015 | 28.39 Billion INR | -5.16% |
| 2014 | 29.94 Billion INR | -0.99% |
| 2013 | 30.24 Billion INR | -21.69% |
| 2012 | 38.61 Billion INR | 37.13% |
| 2011 | 28.16 Billion INR | 33.48% |
| 2010 | 21.09 Billion INR | -16.57% |
| 2009 | 25.28 Billion INR | 13.43% |
| 2008 | 22.29 Billion INR | 48.82% |
| 2007 | 14.98 Billion INR | 41.17% |
| 2006 | 10.61 Billion INR | 26.95% |
| 2005 | 8.35 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.12 Billion INR | 10.99% |
| 2023 Q4 | 1.91 Billion INR | -52.13% |
| 2023 FY | 7.81 Billion INR | -49.12% |
| 2023 Q1 | 3.62 Billion INR | -1.36% |
| 2023 Q2 | 4.66 Billion INR | 28.73% |
| 2023 Q3 | 3.99 Billion INR | -14.38% |
| 2022 FY | 15.35 Billion INR | -21.0% |
| 2022 Q1 | 3.68 Billion INR | 2.27% |
| 2022 Q2 | 4.21 Billion INR | 14.4% |
| 2022 Q3 | 3.79 Billion INR | -9.98% |
| 2022 Q4 | 3.67 Billion INR | -3.17% |
| 2021 Q3 | 5.22 Billion INR | -0.76% |
| 2021 FY | 19.43 Billion INR | 24.23% |
| 2021 Q1 | 5.36 Billion INR | 70.92% |
| 2021 Q2 | 5.26 Billion INR | -1.87% |
| 2021 Q4 | 3.59 Billion INR | -31.07% |
| 2020 Q4 | 3.13 Billion INR | -30.17% |
| 2020 FY | 15.64 Billion INR | -4.02% |
| 2020 Q3 | 4.49 Billion INR | 6.65% |
| 2020 Q2 | 4.21 Billion INR | 10.81% |
| 2020 Q1 | 3.79 Billion INR | 219.15% |
| 2019 Q3 | 4.3 Billion INR | 9.18% |
| 2019 Q2 | 3.93 Billion INR | -3.58% |
| 2019 FY | 16.29 Billion INR | -14.73% |
| 2019 Q4 | 1.19 Billion INR | -72.31% |
| 2019 Q1 | 4.08 Billion INR | -22.59% |
| 2018 Q1 | 5.79 Billion INR | 4.69% |
| 2018 FY | 19.11 Billion INR | -9.97% |
| 2018 Q4 | 5.27 Billion INR | -9.26% |
| 2018 Q3 | 5.81 Billion INR | -8.7% |
| 2018 Q2 | 6.36 Billion INR | 9.94% |
| 2017 Q1 | 4.77 Billion INR | 12.25% |
| 2017 FY | 21.22 Billion INR | -9.77% |
| 2017 Q4 | 5.53 Billion INR | -0.75% |
| 2017 Q3 | 5.57 Billion INR | 1.27% |
| 2017 Q2 | 5.5 Billion INR | 15.19% |
| 2016 Q4 | 4.25 Billion INR | -26.66% |
| 2016 FY | 23.52 Billion INR | -17.15% |
| 2016 Q2 | 6.72 Billion INR | -0.24% |
| 2016 Q1 | 6.73 Billion INR | 10.62% |
| 2016 Q3 | 5.8 Billion INR | -13.65% |
| 2015 Q3 | 6.89 Billion INR | -15.01% |
| 2015 FY | 28.39 Billion INR | -5.16% |
| 2015 Q1 | 7.29 Billion INR | -7.32% |
| 2015 Q2 | 8.11 Billion INR | 11.12% |
| 2015 Q4 | 6.09 Billion INR | -11.62% |
| 2014 Q1 | 6.01 Billion INR | -7.13% |
| 2014 FY | 29.94 Billion INR | -0.99% |
| 2014 Q4 | 7.87 Billion INR | -20.67% |
| 2014 Q3 | 9.92 Billion INR | 62.29% |
| 2014 Q2 | 6.11 Billion INR | 1.62% |
| 2013 FY | 30.24 Billion INR | -21.69% |
| 2013 Q4 | 6.48 Billion INR | -16.44% |
| 2013 Q1 | 8.96 Billion INR | -15.11% |
| 2013 Q3 | 7.75 Billion INR | 10.21% |
| 2013 Q2 | 7.03 Billion INR | -21.45% |
| 2012 Q4 | 10.55 Billion INR | 4.16% |
| 2012 Q1 | 8.51 Billion INR | 9.7% |
| 2012 FY | 38.61 Billion INR | 37.13% |
| 2012 Q2 | 9.41 Billion INR | 10.64% |
| 2012 Q3 | 10.13 Billion INR | 7.65% |
| 2011 Q4 | 7.75 Billion INR | 10.14% |
| 2011 FY | 28.16 Billion INR | 33.48% |
| 2011 Q3 | 7.04 Billion INR | 0.0% |
| 2010 FY | 21.09 Billion INR | -16.57% |
| 2009 FY | 25.28 Billion INR | 13.43% |
| 2008 FY | 22.29 Billion INR | 48.82% |
| 2007 FY | 14.98 Billion INR | 41.17% |
| 2006 FY | 10.61 Billion INR | 26.95% |
| 2005 FY | 8.35 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 39.359% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 89.501% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -30.62% |
| Granules India Limited | 16.79 Billion INR | 3.329% |
| Indoco Remedies Limited | 6.04 Billion INR | -168.815% |
| Achyut Healthcare Limited | 4.86 Million INR | -333987.636% |
| Ajanta Pharma Limited | 21.06 Billion INR | 22.902% |
| Alkem Laboratories Limited | 52.29 Billion INR | 68.947% |
| Alpa Laboratories Limited | 188.89 Million INR | -8497.369% |
| Brooks Laboratories Limited | 65.62 Million INR | -24648.552% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -160.98% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1003.406% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -339.461% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 90.074% |
| Eris Lifesciences Limited | 10.42 Billion INR | -55.753% |
| FDC Limited | 8.33 Billion INR | -94.847% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 76.579% |
| Gufic Biosciences Limited | 4.16 Billion INR | -289.663% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -162.174% |
| Ipca Laboratories Limited | 29.8 Billion INR | 45.521% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2388.546% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -8326.427% |
| Lasa Supergenerics Limited | 121.02 Million INR | -13318.161% |
| Laurus Labs Limited | 24.62 Billion INR | 34.038% |
| Lupin Limited | 123.71 Billion INR | 86.873% |
| Mankind Pharma Limited | 44.52 Billion INR | 63.523% |
| Medicamen Biotech Limited | 495.49 Million INR | -3177.531% |
| Medico Remedies Limited | 262.14 Million INR | -6095.068% |
| Megasoft Limited | 342.07 Million INR | -4647.552% |
| NATCO Pharma Limited | 25.73 Billion INR | 36.898% |
| Piramal Pharma Limited | 24.47 Billion INR | 33.635% |
| RPG Life Sciences Limited | 2.48 Billion INR | -554.048% |
| Sigachi Industries Limited | 2 Billion INR | -711.074% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 93.717% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -293.862% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -1623.262% |
| Unichem Laboratories Limited | 4.86 Billion INR | -233.818% |
| Wanbury Limited | 1.73 Billion INR | -838.38% |
| Windlas Biotech Limited | 1.33 Billion INR | -1113.027% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1181.882% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 87.03% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 2795.856% |
| Divi's Laboratories Limited | 32.44 Billion INR | 49.938% |
| Hester Biosciences Limited | 1.27 Billion INR | -1175.076% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -180.901% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -943.345% |
| Bal Pharma Limited | 770.19 Million INR | -2008.557% |
| Strides Pharma Science Limited | 14.38 Billion INR | -12.871% |
| Venus Remedies Limited | 2.18 Billion INR | -644.072% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -178.495% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -446.422% |
| Shilpa Medicare Limited | 3.54 Billion INR | -357.87% |
| Aarti Drugs Limited | 8.31 Billion INR | -95.281% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -254.523% |
| Suven Life Sciences Limited | -200.79 Million INR | 8187.77% |
| Ind-Swift Limited | 2.17 Billion INR | -647.515% |
| Valiant Laboratories Limited | -60.66 Million INR | 26870.407% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 28.458% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -1785.741% |
| Themis Medicare Limited | 1.5 Billion INR | -979.856% |
| Hikal Limited | 3.14 Billion INR | -416.691% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 65.267% |
| Sequent Scientific Limited | 2.97 Billion INR | -445.199% |
| Novartis India Limited | 1.32 Billion INR | -1123.905% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 17.324% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -111287.751% |
| Neuland Laboratories Limited | 8.24 Billion INR | -96.9% |
| Morepen Laboratories Limited | 6.16 Billion INR | -163.582% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -2517.341% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -2208.113% |